Examination of utility of minodronic acid hydrate to osteoporosis by ovarian insufficiency after gynecologic disease treatment

Trial Profile

Examination of utility of minodronic acid hydrate to osteoporosis by ovarian insufficiency after gynecologic disease treatment

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2016

At a glance

  • Drugs Minodronic acid (Primary)
  • Indications Osteoporosis
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 05 Jul 2016 Status changed from recruiting to completed.
    • 18 Jan 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan
    • 16 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top